Cargando…

Provider-Identified Deprescribing Facilitators and Strategies for Older Adults in Primary Care: A Team Alice Study

Potentially inappropriate medications (PIMs) may harm adults over the age of 65, yet PIMs are prescribed at high rates. The process of deprescribing PIMs is challenging in the primary care setting, particularly among older adult patients with multiple chronic conditions. While barriers to deprescrib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brady, Laura, LaValley, Susan, Ranahan, Molly, Clark, Collin, Monte, Scott, Jacobs, David, Wahler, Robert, Singh, Ranjit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7740390/ http://dx.doi.org/10.1093/geroni/igaa057.1209

Ejemplares similares

ELDER VOICES NETWORK: PARTNERING WITH OLDER PEOPLE AND THEIR CAREGIVERS TO AVOID MEDICAL HARM
por: Ranahan, Molly, et al.
Publicado: (2019)

Knowledge and Attitudes of Student Pharmacists Regarding Polypharmacy and Deprescribing: A Cross-Sectional Study
por: Clark, Collin M., et al.
Publicado: (2020)

Supporting medication discontinuation: provider preferences for interventions to facilitate deprescribing
por: Linsky, Amy, et al.
Publicado: (2017)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

Exploration of Barriers and Facilitators for Deprescribing Opioids and Benzodiazepines to Reduce Older Adult Falls
por: Roberts, Ellen, et al.
Publicado: (2020)

Opportunities and Recommendations for Improving Medication Safety: Understanding the Medication Management System in Primary Care Through an Abstraction Hierarchy
por: Baumgartner, Andrew, et al.
Publicado: (2020)

Emotional barriers and facilitators of deprescribing for older adults with cancer and polypharmacy: a qualitative study
por: Ramsdale, Erika, et al.
Publicado: (2023)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial
por: Mortsiefer, Achim, et al.
Publicado: (2023)

Attitudinal predictors of older peoples’ and caregivers’ desire to deprescribe in hospital
por: Scott, Sion, et al.
Publicado: (2019)

The ACR20 and defining a threshold for response in rheumatic diseases: too much of a good thing
por: Felson, David T, et al.
Publicado: (2014)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Deciphering the Signal From the Noise: Caregivers’ Information Appraisal and Credibility Assessment of Cancer-Related Information Exchanged on Social Networking Sites
por: Gage-Bouchard, Elizabeth A., et al.
Publicado: (2019)

Barriers and facilitators to deprescribing in primary care: a systematic review
por: Doherty, Alison Jayne, et al.
Publicado: (2020)

Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review
por: Brunner, Laureline, et al.
Publicado: (2022)

Prognostic Outcomes of Tall Cell Variant Papillary Thyroid Cancer: A Meta-Analysis
por: Jalisi, Scharukh, et al.
Publicado: (2010)

Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study
por: Abou, Jamila, et al.
Publicado: (2022)

The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients—A Systematic Review
por: Rasmussen, Anja Fog, et al.
Publicado: (2021)

Person-Centred Care Including Deprescribing for Older People
por: Smith, Heather, et al.
Publicado: (2019)

Older people’s attitudes towards deprescribing cardiometabolic medication
por: Crutzen, Stijn, et al.
Publicado: (2021)

Antihypertensive Deprescribing in Older Adults: a Practical Guide
por: Sheppard, James P., et al.
Publicado: (2022)

Potential Targets for Deprescribing in Medically Complex Older Adults with Suspected Cognitive Impairment
por: Pavon, Juliessa M., et al.
Publicado: (2022)

Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trials
por: Ananthakrishnan, Revathi, et al.
Publicado: (2018)

2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy
por: Ananthakrishnan, Revathi, et al.
Publicado: (2019)

Reply
por: Felson, David, et al.
Publicado: (2022)

Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach
por: Lowe, Leroy, et al.
Publicado: (2022)

Deprescribing in Frail Older People: A Randomised Controlled Trial
por: Potter, Kathleen, et al.
Publicado: (2016)

Older Adults’ Awareness of Deprescribing: A Population‐Based Survey
por: Turner, Justin P., et al.
Publicado: (2017)

Potentially inappropriate medication and attitudes of older adults towards deprescribing
por: Achterhof, Alexandra B., et al.
Publicado: (2020)

Deprescribing in older people: helpful tools and proton pump inhibitors
Publicado: (2020)

Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions
por: Wu, Harry, et al.
Publicado: (2021)

Deprescribing in cardiometabolic conditions in older patients: a systematic review
por: Hickman, Elizabeth, et al.
Publicado: (2023)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
por: Le Bosquet, Katherine, et al.
Publicado: (2019)

Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With Dementia
por: Norton, Jonathan D., et al.
Publicado: (2023)

Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study
por: Peat, George, et al.
Publicado: (2022)

Quadriceps Strength After Anterior Cruciate Ligament Reconstruction Compared With Uninjured Matched Controls: A Systematic Review and Meta-analysis
por: Brown, Conlan, et al.
Publicado: (2021)

Reexamining remission definitions in rheumatoid arthritis: considering the twenty-eight–joint Disease Activity Score, C-reactive protein level and patient global assessment
por: Felson, David, et al.
Publicado: (2021)

Reexamining Remission Definitions in Rheumatoid Arthritis: Considering Disease Activity Score in 28 Joints, C‐Reactive Protein, and Patient Global Assessment
por: Felson, David T., et al.
Publicado: (2021)

DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022)

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_foftn23qt568f7triv3a985uu2